Skip to main content
. Author manuscript; available in PMC: 2021 Sep 4.
Published in final edited form as: Br J Dermatol. 2021 May 9;185(3):526–536. doi: 10.1111/bjd.19885

Table 3:

Associations between genetic profiles and atopic dermatitis phenotypes in ALSPAC children

Severe-Frequent*
N=305
Moderate-
Frequent*
N=634
Moderate-
Declining*
N=1008
Mild-Intermittent*
N=845
Chr. Nearest
gene
Global p-
value
RRR (99% CI) RRR (99% CI) RRR (99% CI) RRR (99% CI) Equality p-
value
FLG null mutation 4.26E-32 4.32 (3.07, 6.07) 2.41 (1.81, 3.22) 1.80 (1.39, 2.34) 1.52 (1.13, 2.04) 1.23E-10
Polygenic risk score 1.22E-28 1.67 (1.45, 1.93) 1.37 (1.23, 1.52) 1.17 (1.07, 1.27) 1.13 (1.02, 1.24) 8.60E-11
Individual SNP associations
rs11205006_a 1 LCE5A, FLG-AS1 9.94E-07 1.55 (1.24, 1.93) 1.22 (1.03, 1.44) 1.11 (0.97, 1.28) 1.10 (0.95, 1.28) 3.20E-03
rs2228145_c 1 IL6R 3.69E-04 1.31 (1.06, 1.63) 1.15 (0.99, 1.34) 0.95 (0.83, 1.08) 0.93 (0.81, 1.07) 1.49E-04
rs61813875_g 1 LCE3E, CRCT1 8.63E-10 2.99 (1.79, 4.98) 2.07 (1.34, 3.19) 1.96 (1.36, 2.84) 1.33 (0.84, 2.09) 9.82E-03
rs1057258_c 2 INPP5D 5.81E-02 1.21 (0.90, 1.63) 0.99 (0.81, 1.21) 0.97 (0.82, 1.14) 0.86 (0.72, 1.01) 4.81E-02
rs112111458_a 2 CD207 6.68E-02 1.18 (0.85, 1.65) 1.00 (0.80, 1.25) 1.17 (0.96, 1.42) 0.91 (0.75, 1.10) 4.42E-02
rs13015714_g 2 IL18R1 5.40E-02 1.07 (0.83, 1.38) 1.23 (1.03, 1.47) 1.06 (0.92, 1.24) 1.02 (0.87, 1.20) 1.74E-01
rs17389644_a 4 IL21 9.94E-02 1.17 (0.91, 1.51) 1.07 (0.89, 1.29) 1.15 (0.99, 1.33) 1.02 (0.87, 1.21) 4.36E-01
rs10214237_t 5 IL7R 3.01E-01 0.96 (0.75, 1.21) 1.06 (0.89, 1.26) 1.01 (0.88, 1.17) 1.13 (0.96, 1.32) 3.66E-01
rs2897442_c 5 KIF3A 4.78E-02 1.29 (1.02, 1.63) 1.11 (0.93, 1.32) 0.99 (0.86, 1.15) 0.99 (0.85, 1.16) 4.02E-02
rs12153855_t 6 TNXB 8.75E-03 1.04 (0.72, 1.50) 1.42 (1.06, 1.91) 1.07 (0.86, 1.33) 1.22 (0.96, 1.56) 1.32E-01
rs6473227_c 8 ZBTB10 2.49E-01 1.12 (0.90, 1.40) 1.09 (0.93, 1.28) 1.07 (0.94, 1.22) 1.06 (0.93, 1.22) 9.47E-01
rs10995251_c 10 ZNF365 5.82E-01 0.99 (0.79, 1.23) 0.99 (0.84, 1.16) 1.08 (0.95, 1.24) 1.03 (0.89, 1.18) 5.87E-01
rs12295535_t 11 PRR5L 8.22E-03 1.55 (0.92, 2.61) 1.21 (0.80, 1.84) 1.37 (0.99, 1.91) 0.78 (0.50, 1.22) 1.83E-02
rs479844_g 11 OVOL1 1.17E-05 1.51 (1.21, 1.90) 1.17 (1.00, 1.37) 1.06 (0.93, 1.21) 1.06 (0.92, 1.22) 1.34E-03
rs7127307_t 11 ETS1 5.28E-01 1.05 (0.84, 1.30) 1.07 (0.92, 1.25) 1.00 (0.88, 1.13) 1.07 (0.94, 1.23) 6.39E-01
rs7927894_t 11 C11orf30 2.48E-02 1.21 (0.98, 1.50) 1.09 (0.94, 1.28) 0.96 (0.84, 1.09) 1.10 (0.96, 1.26) 3.74E-02
rs2227483_t 12 IL22 9.80E-01 1.03 (0.83, 1.29) 1.01 (0.86, 1.18) 1.00 (0.88, 1.14) 1.03 (0.90, 1.18) 9.75E-01
rs2143950_t 14 PPP2R3C 1.19E-02 1.24 (0.95, 1.62) 1.26 (1.04, 1.53) 1.01 (0.86, 1.20) 1.06 (0.89, 1.27) 5.74E-02
rs7146581_c 14 TRAF3 1.83E-01 1.09 (0.84, 1.42) 1.16 (0.96, 1.40) 1.09 (0.94, 1.27) 1.04 (0.88, 1.22) 6.78E-01
rs2041733_t 16 CLEC16A 4.41E-01 0.98 (0.79, 1.22) 1.12 (0.96, 1.30) 1.00 (0.88, 1.14) 1.03 (0.90, 1.18) 4.20E-01
rs11657987_t 17 PGS1 9.36E-02 1.22 (0.99, 1.51) 1.09 (0.94, 1.27) 1.02 (0.90, 1.15) 1.06 (0.92, 1.21) 2.44E-01
rs16948048_g 17 ZNF652 7.69E-02 1.18 (0.95, 1.46) 0.92 (0.79, 1.08) 0.98 (0.86, 1.11) 0.92 (0.80, 1.06) 5.50E-02
rs17881320_t 17 STAT3 2.25E-01 1.30 (0.91, 1.86) 1.12 (0.85, 1.47) 1.13 (0.90, 1.41) 1.09 (0.86, 1.39) 7.37E-01
rs2164983_a 19 ACTL9 1.26E-05 1.34 (1.02, 1.77) 1.40 (1.15, 1.70) 1.16 (0.98, 1.37) 1.18 (0.99, 1.42) 1.49E-01
rs6010620_g 20 RTEL1 9.39E-02 1.14 (0.88, 1.47) 1.17 (0.97, 1.41) 1.05 (0.90, 1.21) 1.11 (0.94, 1.30) 6.05E-01
*

compared with the Unaffected/Rare population, n=4990

null hypothesis: RRR1=RRR2=RRR3=RRR4=0

null hypothesis: RRR1=RRR2=RRR3=RRR4. FLG=filaggrin gene; SNP=single nucleotide polymorphism; Chr=chromosome; RRR=relative risk ratio; CI=confidence interval.